| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/09/2003 | EP0708831B1 Cell-density enhanced protein tyrosine phosphatases |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | CN1409764A Pseudomonas aeruginosa antigens |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1409712A Pyrrolo [2,3-d] pyrimidine compounds |
| 04/09/2003 | CN1409640A Polypeptide composition with improved stability |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1408881A Synaptic knob association membrane protein 25 and its use |
| 04/09/2003 | CN1408875A DNA type semliki forest cerebritis virus carrier for expressing IgG1 Fc chimeric protein as TNF receptor |
| 04/09/2003 | CN1408870A Human transcription factor, its coding sequence preparation and use |
| 04/09/2003 | CN1408858A Vermis kinase and its use in therapy of thrombus diseases |
| 04/09/2003 | CN1408857A Method for producing cumic(natto) kinase and cumic (natto) kinase thrombolytic medicine |
| 04/09/2003 | CN1408854A Preparation and application of recombined human betaine homocysteine methyl transferase |
| 04/09/2003 | CN1408726A Preparation of non-mitogenic recombination acid fibrolast growth factor (aFGF) mutant |
| 04/09/2003 | CN1408724A Novel testicular function relative protein and its use |
| 04/09/2003 | CN1408432A Calcium compensation capsule powder and its producing process |
| 04/09/2003 | CN1408431A Gene engineering medicine for curing diseases relative to vascularization |
| 04/09/2003 | CN1408430A Method for producing anti-cancer medicine from silkworm |
| 04/09/2003 | CN1408429A Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor |
| 04/09/2003 | CN1408428A Sugar cane free poly peptide calcium compensation powder and its producing method |
| 04/09/2003 | CN1408427A Reduced type glutathione lozenge |
| 04/09/2003 | CN1408372A Method for using silkworm to express human interleukin 11 to produce medicine |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/09/2003 | CN1104902C Anti-coagulation of blood, blood plasma or synovial fluid products |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104884C Storage stable dentifrice composition containing casein saccharide large molecular peptide |
| 04/09/2003 | CN1104855C Composition and its use as food supplement or for lowering lipids in serum |
| 04/08/2003 | USRE38071 Method for treating infectious respiratory diseases |
| 04/08/2003 | US6545162 Solid phase biosynthesis of viricide antibiotic |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/08/2003 | US6545139 Genetic engineering; anticancer agents |
| 04/08/2003 | US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins |
| 04/08/2003 | US6545131 Tissue specific prodrug |
| 04/08/2003 | US6545129 Human selenoprotein |
| 04/08/2003 | US6545127 Catalytically active recombinant memapsin and methods of use thereof |
| 04/08/2003 | US6545125 Reaction product containing paclitaxel; anticancer agent |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6545123 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545048 Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity |
| 04/08/2003 | US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544978 Treating Alzheimer's disease both prophylactically and therapeutically |
| 04/08/2003 | US6544977 Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide |
| 04/08/2003 | US6544956 Selectively killing a human neoplastic cell by administering a nucleic acid encoding and expressing a peptide comprising at least 8 to 18 contiguous acidic amino acids that are aspartic and glutamic acid |
| 04/08/2003 | US6544955 Method of sensitizing tumor cells with adenovirus E1A |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | US6544950 For therapy of cerebral ischemia and ischemic heart disease including reperfusion injury |
| 04/08/2003 | US6544949 Analogs of parathyroid hormone |
| 04/08/2003 | US6544948 ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 04/08/2003 | US6544947 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using cancer markers |
| 04/08/2003 | US6544946 Inhibitors for use in hemostasis and immune function |
| 04/08/2003 | US6544787 Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation |
| 04/08/2003 | US6544784 Multiple-tumor aberrant growth genes |
| 04/08/2003 | US6544771 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 04/08/2003 | US6544768 Signal transduction; medical diagnosis |
| 04/08/2003 | US6544764 Isolated human dehydrogenase proteins, nucleic acid molecules encoding these human dehydrogenase proteins, and uses thereof |
| 04/08/2003 | US6544761 Nucleotide sequences coding polypeptide for use in treatment of restenosis, arthritis and cancer |
| 04/08/2003 | US6544760 Kunitz domain polypeptide Zkun11 |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544758 Methods for expressing endostatin protein |
| 04/08/2003 | US6544750 Prevent thrombosis |
| 04/08/2003 | US6544749 Antibodies to leukemia inhibitory factor and their use in immunoassays |
| 04/08/2003 | US6544748 Preparation of erythropoietin by endogenous gene activation |
| 04/08/2003 | US6544745 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects |
| 04/08/2003 | US6544743 Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism |
| 04/08/2003 | US6544740 Measuring protease; calibration; insertion of enbryos |
| 04/08/2003 | US6544737 Genomic sequence of the purH gene and purH-related biallelic markers |
| 04/08/2003 | US6544735 Determination gene expression; calibration |
| 04/08/2003 | US6544728 Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2 |
| 04/08/2003 | US6544549 Multilamellar coalescence vesicles (MLCV) containing biologically active compounds |
| 04/08/2003 | US6544548 Hydratable keratin solid which forms a hydrogel upon addition of water for use in nonwoven films, diapers, skin treatments, prosthetic devices, excipients, tissue engineering scaffolds; controlled drug delivery |
| 04/08/2003 | US6544545 Providing needle-less device comprising a barrel member and a plunger, contacting first end of the barrel member to the patient's skin; depressing the plunger, thereby forcing medicament through the skin, to thereby administer medicament |
| 04/08/2003 | US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 04/08/2003 | US6544542 For the administration of a drug which is sparingly soluble in water |
| 04/08/2003 | US6544541 Devices and compounds for treating arterial restenosis |
| 04/08/2003 | US6544526 For immunization of horses |
| 04/08/2003 | US6544523 Mutant forms of Fas ligand and uses thereof |
| 04/08/2003 | US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/08/2003 | US6544520 Isolated, purified peptide that inhibits hepatitis B virus assembly by binding to the core antigen of hepatitis B virus and preventing association |
| 04/08/2003 | US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same |
| 04/08/2003 | US6544514 Compositions comprising, as the main ingredient, allogenic activated-C4+ cells and method for producing and using the same |
| 04/08/2003 | US6544504 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy |
| 04/08/2003 | US6544498 Passing milk or milk-derived ingredient through a cation-exchange resin, and eluting; isoelectric point of 7.5-11; food/drink, toothpaste and gargling agents |
| 04/08/2003 | US6544212 Diabetes management system |
| 04/08/2003 | CA2294305C Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 04/08/2003 | CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2172245C Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein |
| 04/08/2003 | CA2163524C Assay and reagents for identifying anti-proliferative agents |
| 04/08/2003 | CA2160603C Sequence of the hyaluronan receptor gene |
| 04/08/2003 | CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 04/08/2003 | CA2120736C Collagen constructs |
| 04/08/2003 | CA2109830C Lhrh antagonists and intermediate products |
| 04/08/2003 | CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them |
| 04/08/2003 | CA2103829C Peg-interferon conjugates |
| 04/08/2003 | CA2098098C Tetrapeptides deriving from dalbaheptide antibiotics |
| 04/08/2003 | CA2074322C A composition for the sustained and controlled release of medicamentous substances and a process for preparing the same |